financetom
Business
financetom
/
Business
/
OpenAI does not expect to be cash-flow positive until 2029, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI does not expect to be cash-flow positive until 2029, Bloomberg News reports
Mar 26, 2025 12:48 PM

(Reuters) - OpenAI is not expecting its cash flow to turn positive until 2029, Bloomberg News reported on Wednesday, citing a person familiar with the matter.

The San Francisco-based artificial intelligence bellwether is grappling with significant costs from chips, data centers and talent needed to develop cutting-edge AI systems, according to the report.

By 2029, OpenAI expects its revenue will surpass $125 billion. Fueled by the strength of its paid AI software, OpenAI forecast to more than triple its revenue to $12.7 billion in 2025, the report said.

In September last year, Reuters reported that OpenAI was anticipating its revenue would surpass $11.6 billion in 2025, citing sources who were privy to the matter, adding that its revenue in 2024 would touch $3.7 billion, a figure corroborated by the Bloomberg report.

In more than two years since OpenAI rolled out its ChatGPT chatbot, it has introduced a bevvy of subscription offerings for consumers and businesses. In February, its paying business users crossed 2 million, more than double the number from its last update in September.

OpenAI did not immediately respond to a Reuters request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved